HTLV-1-Related Malignant Neoplasm

subtype

Identifier: CI-CAN-00002894
Entity page: /cancer/htlv-1-related-malignant-neoplasm ↗
Edges: 181

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
HTLV-1-Related Malignant Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 60show all (up to 200)
→ investigated in trials for	Fludarabinesmall molecule 18 trials (2 active) · roll-up of the cancer and its descendants	—	—	HTLV-1-Related Malignant Neoplasm	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamide

HTLV-1-Related Malignant Neoplasm studied in …STUDIED_INderived10 of 121show all (up to 200)
→ studied in	NCT01676805recruiting Tissue Collection for Studies of Lymph Cancer · condition mapped ALIAS · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02682667recruiting Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols · condition mapped ALIAS · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04301076Phase 1 · recruiting Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) · condition mapped ONTOLOGY_EXACT · 121 trials mapped (16 active)	—	—	Acute Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07388563Phase 1 · suspended Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03113500Phase 2 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06600568recruiting Novel Therapeutic Approach for Human T-cell Malignancies · condition mapped ONTOLOGY_EXACT · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03264131Phase 2 · completed BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma · condition mapped ONTOLOGY_EXACT · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ALIAS · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04703192Phase 2 · active not recruiting Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) · condition mapped ONTOLOGY_EXACT · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07555431Phase 2 · recruiting Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection · condition mapped ALIAS · 121 trials mapped (16 active)	—	—	Adult T-Cell Leukemia/Lymphoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains